Tokyo Tape
Sign in
← Meiji Holdings

Half-year report · Q2

2269.TEDINET S100UP1S
Period2024-04-01 → 2024-09-30
Filed2024-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥569.0bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥1.11T2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥546.0bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income¥44.4bn2024-04-01 → 2024-09-30Cons.Operating income
Operating income¥44.4bn2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income¥43.3bn2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥76.0bn2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥43.4bn2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax¥44.3bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥48.1bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥26.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥50.7bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥27.9bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income¥29.5bn2024-04-01 → 2024-09-30Cons.Profit loss
Net income¥30.4bn2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥1.18Tat 2024-09-30Cons.Assets
Total assets¥1.21Tat 2024-03-31Cons.Assets
Total assets¥1.21Tat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥401.2bnat 2024-09-30Cons.Liabilities
Total liabilities¥417.5bnat 2024-03-31Cons.Liabilities
Net assets / equity¥774.6bnat 2024-09-30Cons.Net assets
Net assets / equity¥787.8bnat 2024-03-31Cons.Net assets
Net assets / equity¥786.7bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥78.8bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥106.9bnat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥73.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥102.8bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥78.4bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥60.9bnat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow¥3.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥108.0bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥25.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥12.2bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥24.6bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥17.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥43.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥97.662024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.642023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥100.132023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.2%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio61.9%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio61.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥318m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥318m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥1.8bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2024-04-01 → 2024-09-30¥455.4bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2024-04-01 → 2024-09-30¥455.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥307m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2024-04-01 → 2024-09-30¥27.6bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2024-04-01 → 2024-09-30¥113.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2024-04-01 → 2024-09-30¥113.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥10m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2024-04-01 → 2024-09-30¥18.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥569.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥569.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥318m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥46.2bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥303m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue2023-04-01 → 2023-09-30¥445.5bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue external2023-04-01 → 2023-09-30¥445.2bn
jpcrp040300-q2r_E21902-000Foodreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥293m
jpcrp040300-q2r_E21902-000Foodreportable segmentsegment profit2023-04-01 → 2023-09-30¥29.7bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue2023-04-01 → 2023-09-30¥100.9bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue external2023-04-01 → 2023-09-30¥100.8bn
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥9m
jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segmentsegment profit2023-04-01 → 2023-09-30¥15.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥546.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥546.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥303m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥45.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 542
ItemContextValueUnit
Subsidy eiCurrentYTDDuration8000000JPY
Other eiPrior1YTDDuration2722000000JPY
Other eiCurrentYTDDuration14000000JPY
Extraordinary incomePrior1YTDDuration7766000000JPY
Extraordinary incomeCurrentYTDDuration4033000000JPY
Loss on abandonment of noncurrent assets elPrior1YTDDuration1872000000JPY
Loss on abandonment of noncurrent assets elCurrentYTDDuration2692000000JPY
Loss on reduction of noncurrent assets elPrior1YTDDuration532000000JPY
Loss on reduction of noncurrent assets elCurrentYTDDuration8000000JPY
Other elPrior1YTDDuration742000000JPY
Other elCurrentYTDDuration428000000JPY
Extraordinary lossPrior1YTDDuration3147000000JPY
Extraordinary lossCurrentYTDDuration3129000000JPY
Income before income taxesPrior1YTDDuration48053000000JPY
Income before income taxesCurrentYTDDuration44251000000JPY
Income taxesPrior1YTDDuration17651000000JPY
Income taxesCurrentYTDDuration14773000000JPY
Profit lossPrior1YTDDuration30401000000JPY
Profit lossCurrentYTDDuration29477000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration2479000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration2610000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration27921000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration26867000000JPY
Profit lossPrior1YTDDuration30401000000JPY
Profit lossCurrentYTDDuration29477000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration4467000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-2381000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration177000000JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration-199000000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration10955000000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration-4401000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration148000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration448000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration2035000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration3041000000JPY
Other comprehensive incomePrior1YTDDuration17783000000JPY
Other comprehensive incomeCurrentYTDDuration-3492000000JPY
Comprehensive incomePrior1YTDDuration48185000000JPY
Comprehensive incomeCurrentYTDDuration25985000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration45578000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration23356000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration2606000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration2628000000JPY
Income before income taxesPrior1YTDDuration48053000000JPY
Income before income taxesCurrentYTDDuration44251000000JPY
Depreciation and amortization ope cfPrior1YTDDuration26871000000JPY
Depreciation and amortization ope cfCurrentYTDDuration27569000000JPY
Impairment loss ope cfPrior1YTDDuration129000000JPY
Impairment loss ope cfCurrentYTDDuration171000000JPY
Loss on retirement of property plant and equipment ope cfPrior1YTDDuration1856000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass